Breathing New Life into Diagnostics: Plasmion’s SICRIT® Technology

FHS
June 11, 2024
12:47 pm

Revolutionizing Non-Invasive Diagnostics with Plasmion’s SICRIT Breath Analysis.

Novel antidepressant zuranolone effective in alleviating depression and anxiety symptoms

The efficacy and safety of zuranolone in treating major depressive disorder (MDD).

November 20, 2023

FDA offers clarity on post-warning letter meetings in new draft guidance

FDA on Friday published draft guidance laying out its approach to post-warning letter meetings for generic drugmakers, including the criteria for granting the meetings and

September 2, 2023

Congressman’s Stroke; Warning on Bear Meat Consumption; Paralysis via Grand Piano

Note that some links may require registration or subscription. Also note that in observance of the Memorial Day holiday, our Morning Break feature will not

May 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.